Merrimack Pharma (MACK), PharmaEngine Enter Amended Licensing Agreement for MM-398 (BAX)
Tweet Send to a Friend
PharmaEngine, Inc., announced that the company has signed an Amendment to its License Agreement of MM-398 (aka PEP02, nanoliposomal irinotecan ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
